Literature DB >> 34456638

Molecular Imaging Biomarkers in Dementia: Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.

Brad Dickerson1, Alireza Atri2.   

Abstract

Entities:  

Year:  2020        PMID: 34456638      PMCID: PMC8387980     

Source DB:  PubMed          Journal:  Pract Neurol (Fort Wash Pa)        ISSN: 1540-1367


× No keyword cloud information.
  38 in total

1.  [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.

Authors:  Marta Marquié; Michael Siao Tick Chong; Alejandro Antón-Fernández; Eline E Verwer; Nil Sáez-Calveras; Avery C Meltzer; Prianca Ramanan; Ana C Amaral; Jose Gonzalez; Marc D Normandin; Matthew P Frosch; Teresa Gómez-Isla
Journal:  Acta Neuropathol       Date:  2017-06-13       Impact factor: 17.088

2.  Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

Authors:  Adam J Schwarz; Peng Yu; Bradley B Miller; Sergey Shcherbinin; James Dickson; Michael Navitsky; Abhinay D Joshi; Michael D Devous; Mark S Mintun
Journal:  Brain       Date:  2016-03-02       Impact factor: 13.501

3.  Reply: Limbic-predominant age-related TDP-43 encephalopathy (LATE).

Authors:  Julie A Schneider; Peter T Nelson
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

4.  Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

Authors:  David Bergeron; Maria L Gorno-Tempini; Gil D Rabinovici; Miguel A Santos-Santos; William Seeley; Bruce L Miller; Yolande Pijnenburg; M Antoinette Keulen; Colin Groot; Bart N M van Berckel; Wiesje M van der Flier; Philip Scheltens; Jonathan D Rohrer; Jason D Warren; Jonathan M Schott; Nick C Fox; Raquel Sanchez-Valle; Oriol Grau-Rivera; Ellen Gelpi; Harro Seelaar; Janne M Papma; John C van Swieten; John R Hodges; Cristian E Leyton; Olivier Piguet; Emily J Rogalski; Marsel M Mesulam; Lejla Koric; Kristensen Nora; Jeéreémie Pariente; Bradford Dickerson; Ian R Mackenzie; Ging-Yuek R Hsiung; Serge Belliard; David J Irwin; David A Wolk; Murray Grossman; Matthew Jones; Jennifer Harris; David Mann; Julie S Snowden; Patricio Chrem-Mendez; Ismael L Calandri; Alejandra A Amengual; Carole Miguet-Alfonsi; Eloi Magnin; Giuseppe Magnani; Roberto Santangelo; Vincent Deramecourt; Florence Pasquier; Niklas Mattsson; Christer Nilsson; Oskar Hansson; Julia Keith; Mario Masellis; Sandra E Black; Jordi A Matías-Guiu; María-Nieves Cabrera-Martin; Claire Paquet; Julien Dumurgier; Marc Teichmann; Marie Sarazin; Michel Bottlaender; Bruno Dubois; Christopher C Rowe; Victor L Villemagne; Rik Vandenberghe; Elias Granadillo; Edmond Teng; Mario Mendez; Philipp T Meyer; Lars Frings; Alberto Lleó; Rafael Blesa; Juan Fortea; Sang Won Seo; Janine Diehl-Schmid; Timo Grimmer; Kristian Steen Frederiksen; Pascual Sánchez-Juan; Gaël Chételat; Willemijn Jansen; Rémi W Bouchard; Robert Jr Laforce; Pieter Jelle Visser; Rik Ossenkoppele
Journal:  Ann Neurol       Date:  2018-11       Impact factor: 10.422

5.  Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.

Authors:  Adam S Fleisher; Michael J Pontecorvo; Michael D Devous; Ming Lu; Anupa K Arora; Stephen P Truocchio; Patricia Aldea; Matthew Flitter; Tricia Locascio; Marybeth Devine; Andrew Siderowf; Thomas G Beach; Thomas J Montine; Geidy E Serrano; Craig Curtis; Allison Perrin; Stephen Salloway; Misty Daniel; Charles Wellman; Abhinay D Joshi; David J Irwin; Val J Lowe; William W Seeley; Milos D Ikonomovic; Joseph C Masdeu; Ian Kennedy; Thomas Harris; Michael Navitsky; Sudeepti Southekal; Mark A Mintun
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

6.  18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.

Authors:  Daniel R Schonhaut; Corey T McMillan; Salvatore Spina; Bradford C Dickerson; Andrew Siderowf; Michael D Devous; Richard Tsai; Joseph Winer; David S Russell; Irene Litvan; Erik D Roberson; William W Seeley; Lea T Grinberg; Joel H Kramer; Bruce L Miller; Peter Pressman; Ilya Nasrallah; Suzanne L Baker; Stephen N Gomperts; Keith A Johnson; Murray Grossman; William J Jagust; Adam L Boxer; Gil D Rabinovici
Journal:  Ann Neurol       Date:  2017-10       Impact factor: 10.422

7.  Primary age-related tauopathy (PART): a common pathology associated with human aging.

Authors:  John F Crary; John Q Trojanowski; Julie A Schneider; Jose F Abisambra; Erin L Abner; Irina Alafuzoff; Steven E Arnold; Johannes Attems; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Marla Gearing; Lea T Grinberg; Patrick R Hof; Bradley T Hyman; Kurt Jellinger; Gregory A Jicha; Gabor G Kovacs; David S Knopman; Julia Kofler; Walter A Kukull; Ian R Mackenzie; Eliezer Masliah; Ann McKee; Thomas J Montine; Melissa E Murray; Janna H Neltner; Ismael Santa-Maria; William W Seeley; Alberto Serrano-Pozo; Michael L Shelanski; Thor Stein; Masaki Takao; Dietmar R Thal; Jonathan B Toledo; Juan C Troncoso; Jean Paul Vonsattel; Charles L White; Thomas Wisniewski; Randall L Woltjer; Masahito Yamada; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2014-10-28       Impact factor: 17.088

8.  Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.

Authors:  Leslie M Shaw; Jalayne Arias; Kaj Blennow; Douglas Galasko; Jose Luis Molinuevo; Stephen Salloway; Suzanne Schindler; Maria C Carrillo; James A Hendrix; April Ross; Judit Illes; Courtney Ramus; Sheila Fifer
Journal:  Alzheimers Dement       Date:  2018-10-10       Impact factor: 16.655

9.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Authors:  Michael J Pontecorvo; Michael D Devous; Michael Navitsky; Ming Lu; Stephen Salloway; Frederick W Schaerf; Danna Jennings; Anupa K Arora; Anne McGeehan; Nathaniel C Lim; Hui Xiong; Abhinay D Joshi; Andrew Siderowf; Mark A Mintun
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

10.  LATE to the PART-y.

Authors:  Keith A Josephs; Ian Mackenzie; Matthew P Frosch; Eileen H Bigio; Manuela Neumann; Tetsuaki Arai; Brittany N Dugger; Bernardino Ghetti; Murray Grossman; Masato Hasegawa; Karl Herrup; Janice Holton; Kurt Jellinger; Tammaryn Lashley; Kirsty E McAleese; Joseph E Parisi; Tamas Revesz; Yuko Saito; Jean Paul Vonsattel; Jennifer L Whitwell; Thomas Wisniewski; William Hu
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.